Skip to content
Angela Lamarca· @DrAngelaLamarca · X·· 3 days agoScore70

ELI-002

Body · original

Proffered paper on #PDAC by @EileenMOReilly at @myESMO #ESMO26 - AMPLIFY-7P

Randomized phase II trial
Stage II-III KRAS-mutated respected PDAC - adjuvant Camupepimut (ELI-002 7P)

Phase-III ongoing based on promising prespecified DFS at 6m data

#ESMOAmbassadors

222 views · 2 likes · 0 reposts · 0 replies

Conference abstracts
7Pmatched by Proffered paper 1: Gastrointestinal tumour, upper digestive

Proffered paper 1: Gastrointestinal tumour, upper digestive

https://esmocongress.esmo.org

Source: Angela Lamarca · x.com

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org

Disclaimer CBA Frontier Insights uses AI-assisted methods to aggregate, summarize, and analyze publicly accessible biopharmaceutical information. Content is provided for informational and educational purposes only and does not represent the official views of original sources or affiliated organizations. AI-generated content may contain errors; please verify important information against primary sources. Intellectual property rights remain with their respective owners. For copyright concerns or corrections, please contact us through the website’s feedback page.